Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great GRAY news and progress 5/27!
Volume have been ridiculously low for 6 months now so it's about time.. As seen with ASK going higher...
GLTA
Sure hope so!
Hoorah TLSS
TLSS 5/26/2022 acquisition of Freight Connections:
"Transportation and Logistics Systems, Inc. (OTCQB: TLSS), (“TLSS” or the “Company”), a logistics service provider, announced that, on May 23, 2022, its wholly-owned subsidiary, TLSS Acquisition, Inc. (the “Acquisition Sub”), entered into a stock purchase agreement dated as of May 23, 2022 (“SPA”), to acquire all of the outstanding stock of Freight Connections, Inc., a New Jersey-based full service logistics provider specializing in pickup, warehousing and delivery services in the tri-state area (“Freight Connections”).
Freight Connections is a full-service transportation business that has been in operation for approximately 10 years providing transportation, warehousing, consolidating, distribution, and local cartage services to a diverse base of more than 500 commercial accounts.
- It utilizes its own fleet of trucks, warehouse/driver/office personnel and on-call independent contractors from its three convenient and secure New Jersey locations comprising approximately 200,000 square feet of warehouse space, allowing it to pick-up and deliver throughout the tri-state area.
- The SPA provides for a purchase price equal to approximately $7,000,000 based upon the following formula: five (5) times verifiable twelve (12) months trailing earnings before interest, taxes, depreciation and amortization (“EBITDA”), to be adjusted to exclude any selling shareholder-related or one-time expenses, plus or minus, as applicable, the excess or deficiency of Freight Connections’ net working capital at closing as compared to a target equal to the average month-end net working capital for each of the 12 months prior to Closing.
- The Total Consideration will be payable as follows: (i) $4,000,000 payable in cash, at Closing; (ii) a secured, 4-yr. 5% promissory note in the amount of $500,000, subject to reduction for any debt assumed by the buyer, and convertible after a year at the holder’s option into TLSS common stock at the average closing price of such common stock on the five trading days prior to Closing; and (iii) the balance in common stock of TLSS, but net working capital adjustment in cash.
- The sole selling shareholder of Freight Connections will also enter into an employment agreement to continue with the company and a non-competition agreement.
- The transaction is scheduled to close approximately 60 days after the execution of Agreement, subject to the completion of satisfactory due diligence by TLSS to confirm the accuracy of all of Freight Connection’s representations and warranties in the SPA and that Freight Connections has not suffered a material adverse change in its business, and also subject to Freight Connections’ procuring an acceptable landlord’s consent to Freight Connections’ assignment of the leases for its warehouse operating facilities to the Acquisition Sub, and also subject to TLSS’s securing financing for the cash portion of the acquisition.
- The Company’s primary strategy has been to become a leader in the transportation industry in providing on-time, high-quality pick-up, transportation and delivery services. The Company expects to accomplish this goal, in part, by pursuing strategic acquisitions as a means of adding new markets in the United States, expanding its transportation and logistics service offerings, adding talented management and operational employees, expanding and upgrading its technology platform and developing operational best practices. Moreover, one factor in assessing acquisition opportunities is the potential for subsequent organic growth post-acquisition.
- The Company believes that the acquisition of Freight Connections is an excellent fit with its current business given its demographic location, services offered, and diversified customer base, and given that it would provide the Company with a long-standing, well-run profitable operation. Furthermore, the Company believes that, because Freight Connections is strategically based in New Jersey and serves the tri-state area, organic growth opportunities will be available for expanding its footprint into the Company’s primary base of operations near New York’s JFK Airport, as well as efficiencies that could be derived by leveraging the Company’s existing Cougar Express subsidiary’s operational capabilities."
https://ih.advfn.com/p.php?pid=nmona&article=88220925
GLTA
TLSS doesn't care about pps so likely no r/s - just delisting UNLESS they have a deal in their back pocket. Anybody's guess...
GLTA
What’s in TLSS 8k just out 5:05pm?
http://delivery.sec.report/JEIBQX?id=95272=dBkCBgwHBAMLS1ACAlUIUVECA1VQB1oLB1YPXwBWBwZWVwMCDAsABglTAFJVBQAFBABKDVoGCV9fCUpQXnNdR1RLQEQbUVlZRQYDUQJQAVRbUAdXB1FUDAZVRFFER0ULGEpWU1lbQFFLThsXVAceEQcWWRFHSih8eiRpYQ9aUU1BVg==&fl=XxFGRkYIGRtKUlZKQwFADBASGSdcBhdUVghMFgADBQADXAEHAAAbBgsaBVUFXQNbTQ==
GLTA
Any why would another Big-Pharma not buy this patent or partner with SNGX for use?
GLTA
SNGX should now move back to normal pps..
GLTA
SNGX looking UP with avg $6 price target !
"Investors Observer is giving Soligenix, Inc. Common Stock (SNGX) an Analyst Rating Rank of 4, meaning SNGX is ranked higher by analysts than 4% of stocks. The average price target for SNGX is $6 and analyst’s rate the stock as a Hold."
https://www.investorsobserver.com/news/stock-update/do-analysts-agree-wednesday-on-soligenix-inc-common-stock-sngx-stocks-target-price
GLTA
"Sources told Vanity Fair"... Thats seems legit...
DWAC here to stay & continue UP...
GLTA
I doubled my IMPP position. It only reduced my average to .84.
I dont expect immediate return, but looks like good strong long term.
GLTA
IMPP entire offering already bought UP 1st 20min of market open...
GLTA
IMPP 1/2 the new 72m already gobbled up pre-market so hopefully float gets locked up ? That’s half the OS so…
GLTA
Yeah this was another mistake.
I won’t add more trash to this trash…
GLTA
SNGX p/r 5/13/2022: "Soligenix Announces Recent Accomplishments And First Quarter 2022 Financial Results.
PRINCETON, N.J., May 13, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended March 31, 2022.
Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix stated, "We remain focused on our significant upcoming milestones for 2022. We anticipate submitting a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing authorization of HyBryte™ (SGX301 or synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL) in the second half of this year. We expect to initiate a Phase 2a clinical trial in mild-to-moderate psoriasis with SGX302 (synthetic hypericin) in the second half of this year as well. With approximately $22.9 million in cash, not including our non-dilutive government funding, we anticipate having the capital required to achieve our near-term milestones, including NDA filing and expansion into psoriasis with the initiation of the Phase 2a clinical study."
Dr. Schaber continued, "Supported by funding from the National Institute of Allergy and Infectious Diseases, our Public Health Solutions business segment continues to achieve key objectives with our heat stable vaccine platform technology, ThermoVax®. Recently, we announced results of a booster vaccination study using CiVax™ (heat stable COVID-19 subunit vaccine program) in non-human primates (NHPs) demonstrating rapid enhancement of neutralizing antibody responses to SARS-CoV-2, including against Delta and Omicron variants. As always, we continue to evaluate various strategic options, including but not limited to, partnership and merger and acquisition opportunities."
Soligenix Recent Accomplishments
On April 19, 2022, the Company announced it had received approximately $1.4 million, net of transaction costs, in non-dilutive funding via multiple government tax programs. To view this press release, please click here.
On March 17, 2022, the Company announced the results of a booster vaccination study using CiVax™ (heat stable COVID-19 subunit vaccine program) in NHPs demonstrating rapid enhancement of neutralizing antibody responses to SARS-CoV-2, including against Delta and Omicron variants. To view this press release, please click here.
Financial Results – Year Ended March 31, 2022
Soligenix's revenues for the quarter ended March 31, 2022 were $0.2 million as compared to $0.1 million for the quarter ended March 31, 2021. Revenues primarily included payments on government contracts and grants received to support the development of: RiVax®, our ricin toxin vaccine candidate; SGX943, for treatment of emerging and/or antibiotic-resistant infectious diseases; ThermoVax®, our thermostabilization platform technology; and CiVax™, our vaccine candidate for the prevention of COVID-19.
Soligenix's basic net loss was $4.3 million, or ($0.10) per share, for the quarter ended March 31, 2022, as compared to $2.4 million, or ($0.06) per share, for the quarter ended March 31, 2021. The increase in net loss was primarily attributed to an increase in legal and consulting services associated with the arbitration against Emergent BioSolutions, Inc. and certain of its subsidiaries as well as an increase in research and development expenses associated with preparation of the upcoming HyBryte™ NDA filing.
Research and development expenses were $1.7 million as compared to $1.3 million for the quarter ended March 31, 2022 and 2021, respectively. The increase in research and development spending for the quarter ended March 31, 2022 was primarily attributable to the increased expenses associated with preparation of the upcoming HyBryte™ NDA filing."
https://ih.advfn.com/p.php?pid=nmona&article=88104396
GLTA
..
..
SNGX after hours death spiral.
WTH???
SNGX 40 cents??!! WTH
SNGX cup has CRACKed...
WTH
DWAC. money, money, money song...
YES
What the F ATER??!!
DWAC only down on 70% less avg volume.
Easy to see what next 10 days could mean.
GLTA
Nice work Cash. DWAC spring loaded.
GLTA
Last "rate hike week" I sold a tad, and missed the run UP.
Here we are for 2nd rate hike announcement 2022, and Gold sure dipping a bit...
BUY opportunity here at JNUG???
GLTA
Last "rate hike week" I sold a tad, and missed the run UP.
Here we are for 2nd rate hike announcement 2022, and Gold sure dipping a bit...
BUY opportunity here at GDXU???
GLTA
Good to see you join us on Truth Social.
DWAC 2022.
GLTA
What’s FB look like Friday? Next week?
Back to 12mo average over $300?
GLTA
FB looking good. Should continue rest of week forward...
Also shows FB debt vs $48b cash on hand...
Debt likely only revolves real estate which could be worth 2x that.
GLTA
Nice discount today. So FB $375, $325, and $290 on the low...
GLTA
Yeah that worked out (article is old - 2days prior to confirmation of acquisition...)...
DWAC with 10x memebers each year forward.
DWAC looooking Goooood !
Like this we didn't see this coming?!! Again?!!!
GLTA
GRAY 4/27/2022: Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting May 1-4, 2022.
" Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a poster presentation of preclinical data for GB-401 in primary open-angle glaucoma (POAG) at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, to be held at the Colorado Convention Center in Denver from May 1-4, 2022.
Information is listed below and available on the ARVO website.
In Vitro and In Vivo Characterizations of GB-401, a Sustained-Release Intravitreal Implant Containing a Beta-Adrenergic Antagonist Prodrug for POAG
Presenter: Yun Yu, PhD, Associate Director R&D, Graybug Vision
Poster Session: Drug Delivery
Date and Time: Wednesday May 4, 2022; 12:30 – 2:30 PM MT (2:30 – 4:30 PM ET). Location: Poster Hall - F0151 "
GLTA
..
..
I'm sure thier acquisitions had some speed bumps (don't they all?) .
This 1 we're all looking for can potentially double their size/revenue = TIME.
I also am tied to Supply Chain 25+ years, and understand the focus on business that was needed in Q1 likely delayed other priorities.
Not by any means making excuses for people I do not know.
Just giving my opinion, and I was happy to read today's PR which at first I thought would be BS/fluff.
GLTA
TLSS management took the time to ease concerns for this sub-penny stock, and ensure progress near term. They are concentrating on both acquisitions + profitability.
That demonstrates shareholder VALUE. (If I didn't see this within the next 10 days I may have sold).
GLTA
At 1st I thought fluff too, but NO.
TLSS addressed all concerns especially: "the balance of 2022 will be driven, to a large degree, by what transpires in Q1 related to acquisitions…"
What's Ahead in Q2. The business objectives for the second quarter are straight-forward:
"enter into definitive agreements on acquisition opportunities, where appropriate;
implement our new, upgraded operating and financial reporting systems;
resolve the warehouse space needs for our Cougar Express subsidiary;
continue to favorably resolve outstanding claims and litigation; and
improve operating margins.".
4/27/2022 TLSS update link: https://www.accesswire.com/698951/TLSS-Chairman-Issues-Shareholder-Update
GLTA
Thanks Boo I assume same, but that is still 2 months out - June 20.
Watching pre-market hours every day - the ASK is 20-30% higher than the BID, and also 20-30% higher than actual current PPS. Seems to be obvious manipulation since we have not seen more than 350k traded in many Months now...
GLTA
Oh yes - competition it will be!
Please be advised - I joined TS & posted what would be immediately taken down on ALL other Social Media, and my multiple posts remain up as tests.
100% Feedom of Speach on Truth Social so far...
GLTA
Why is nobody talking about how much DWAC Musk own?
You all know he's got some (and does Elon own only a little anything?)...
He consitently talks about TRUTH and Free Speech...
GLTA
Wow. Now .51... I see no SNGX filings???
MMs really taking out all STOPs...
GLTA
WTH today 4/25 SNGX?
How did .55s hit???
GLTA